Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
UN mission says no evidence Hezbollah rearming in southern Lebanon - 2Step by step instructions to Look at Compact disc Rates: A Thorough Aide
- 3Somaliland denies trading recognition with Israel for accepting Gazans
- 4Unsold Rams May Be Less expensive Than You Suspect
- 5At least 11 killed in South Africa mass shooting
- A decade after Brazil’s deadly dam collapse, Indigenous peoples demand justice on the eve of COP30
- Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices
- What's going around right now? COVID, flu, stomach bug on the rise
- Figure out How to Acquire Rewarding Open Record Rewards
- NASA's Perseverance Mars rover could break the record for miles driven on another planet
- Why the Houthis waited until now to strike
- ‘Serving is not just a place’: Bayside Church Granite Bay reimagines annual mission amid conflict in Mexico
- Qatar LNG Ships U-Turn After Attempt to Pass Through Hormuz
- ByHeart sued over recalled formula by parents of infants sickened with botulism
